Baylor College of Medicine: Protein EIF4A Emerges as a Potential Achilles' Heel for Triple-Negative Breast Cancer
October 31, 2023
October 31, 2023
HOUSTON, Texas, Oct. 31 (TNSres) -- The Baylor College of Medicine issued the following news:
Improving treatments for triple-negative breast cancer (TNBC), an aggressive tumor with very poor prognosis and limited therapeutic targets, has been challenging. Responding to this need for better treatments, researchers at Baylor College of Medicine and collaborating institutions have investigated potential vulnerabilities in TNBC that could lead to novel therapies and improved outcomes f . . .
Improving treatments for triple-negative breast cancer (TNBC), an aggressive tumor with very poor prognosis and limited therapeutic targets, has been challenging. Responding to this need for better treatments, researchers at Baylor College of Medicine and collaborating institutions have investigated potential vulnerabilities in TNBC that could lead to novel therapies and improved outcomes f . . .